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Vancomycin-resistant Enterococcus faecium strains (VRE) were isolated from human wastewater but not
swine fecal waste from a semiclosed agri-food system in Texas. Forty-nine VRE isolates possessed vanA, and
one possessed vanB. Twenty-one pulsed-field gel electrophoresis types were identified and segregated into three
groups. There was evidence of clonal dissemination among geographically separated sites.
Many factors are involved in the global dissemination of
vancomycin-resistant enterococci (VRE), as evidenced by the
emergence of Enterococcus faecium complex 17 (22). VRE are
highly prevalent among hospitals in the United States (2, 6)
and have been reported from hospital wastewater but have not
been isolated from livestock or any healthy human population
(4, 7, 10, 16, 18, 20). There has been speculation that VRE
exist among the general population in the United States and
that more should be done to identify community carriage of
VRE so control measures can be instituted (14).
The vanA gene cluster, which confers high-level resistance to
vancomycin and teicoplanin, is located on transposon Tn1546
and consists of seven genes: vanR, vanS, vanH, vanA, vanX,
vanY, and vanZ (1). Genotypic characterization of mobile ge-
netic elements, such as Tn1546, can be done independently
from chromosomal analysis of individual clones, thus providing
information on the transmission of the mobile element (5, 19,
21).
The purpose of this study was to characterize the VRE
isolated from human wastewater effluents located within an
integrated semiclosed agri-food system in Texas. This is the
first known report of VRE shedding from a largely nonclinical
community population in the United States.
Study population. The study population and sampling pro-
cedures have been previously described (17). Briefly, the study
population consisted of humans and swine at 18 geographically
separated farm and non-farm sites in Texas. Thirteen sites
housed both swine and human cohorts. Within the study group,
swine worker facilities housed 3,000 people, while non-swine
worker facilities housed 18,000 people. Wastewater effluent
from swine worker and non-swine worker dormitories drained
into a central lift station and proceeded to a wastewater treat-
ment plant. Each of the seven facilities that yielded VRE had
its own separate wastewater treatment plant, such that VRE
dissemination between facilities via wastewater would not have
been likely. Swine fecal samples consisted of composite feces
and lagoon samples. The swine breeding program was self-
sustaining, and swine were not moved between farm sites.
Those used for food production were moved to a single slaugh-
ter facility, where they were processed and consumed within
the system. Approximately 50,000 swine were slaughtered each
year.
VRE. From October 2002 to August 2004, 1,252 human
effluent and 1,270 swine fecal or effluent samples were ana-
lyzed for enterococci. VRE were isolated on M-enterococcus
agar (Becton Dickinson, Sparks, MD) containing 20 g/ml
vancomycin and were incubated for 48 h at 45°C. Isolates from
M-enterococcus agar were identified as E. faecium by the API
20 Strep system (bioMerieux, Hazelwood, MO) and PCR as
described by Jackson et al. (11).
The MICs of the antimicrobials were determined by broth
microdilution according to methods described by the Clinical
Laboratory Standards Institute (3). Fifty enterococci that dem-
onstrated high-level resistance to vancomycin (512 g/ml)
were isolated from human wastewater. No VRE were isolated
from swine samples (Table 1). All VRE were susceptible to
daptomycin, linezolid, and quinupristin-dalfopristin. Ninety-
two percent of the VRE exhibited macrolide and lincosamide
resistance. Seventy-four percent of the VRE isolates exhibited
high-level resistance to gentamicin (1,024 g/ml).
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TABLE 1. Total number of samples selectively screened for all
enterococci and VRE by year, host species, and sample origin
Host species Sample origin
No. of samples by yra
2002 2003 2004
Human Swine worker 0 21/223 5/211
Non-swine worker 0 1/79 11/369
Mixtureb 3/27 5/171 4/172
Swine Composite fecal 47 77 809
Influent 16 18 303
a Boldfaced numbers are the number of VRE isolates obtained from the
sample groups.
b Mixture means samples composed of non-swine worker and swine worker
wastewater or samples taken from the central core facility or hospital facility that
does not include swine workers.
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FIG. 1. Dendrogram illustrating relatedness of 21 PFGE types. The bar indicates the percent similarity coefficient.
TABLE 2. Geographic location, PFGE type, and date of VRE isolate recoverya
Isolate (PFGE type) and date (mo/day/yr) of recovery at location (facility type):
TX1 (farm affiliated) TX2 (farm affiliated) TX3 (farm affiliated) TX4 (farm affiliated) TX5 (farm affiliated) TX6 (hospital) TX7 (CCF)
14 (A) 6/6/03 22 (L) 6/6/03 25 (C) 6/6/03 143 (A) 7/1/03 301 (T) 4/9/04 373 (N) 5/3/04 VB (S) 10/4/02
15 (A) 6/6/03 23 (B) 6/6/03 29 (A) 6/6/03 144 (A) 7/1/03 700 (F) 8/6/04 593 (N) 6/18/04 653 (R) 7/12/04
16 (D) 6/6/03 24 (A) 6/6/03 60 (A) 6/6/03 145 (A) 7/1/03 701 (G) 8/6/04 594 (P) 6/18/04 654 (Q) 7/12/04
17 (D) 6/6/03 50 (A) 6/6/03 146 (A) 7/1/03 702 (E) 8/6/04 749 (K) 8/16/04
18 (A) 6/6/03 51 (A) 6/6/03 147 (A) 7/1/03 703 (G) 8/6/04 751 (J) 8/16/04
19 (A) 6/6/03 223 (A) 7/24/03 246 (U) 4/9/04
54 (A) 6/6/03 224 (A) 7/24/03 261 (H) 7/24/03
225 (A) 7/24/03 262 (H) 7/15/03
226 (A) 7/24/03 280 (H) 7/31/03
228 (A) 7/24/03 282 (H) 7/29/03
336 (A) 4/20/04 284 (H) 7/29/03
337 (A) 4/20/04 672 (M) 8/6/04
338 (A) 4/20/04 9561 (O) 10/4/02
9674 (I) 10/4/02
a Farm affiliated, facility with both a swine farm and human dormitory; human hospital, no swine; CCF, central core facility for human personnel. Isolates in boldface
do not have IS1251.
VOL. 49, 2005 NOTES 4383
 o
n
 Septem
ber 11, 2018 by guest
http://aac.asm
.org/
D
ow
nloaded from
 
PCR genotyping of vanA, vanB, and vanC VRE has been
previously described (8). Forty-nine E. faecium isolates pos-
sessed the vanA gene cluster, and one, VB, carried the vanB
gene cluster. All VRE exhibiting high-level resistance to gen-
tamicin were shown to possess the bifunctional gene (acc6-
aph2) that confers high-level resistance to aminoglycosides.
Forty-three VRE isolates (86%) possessed the rRNA methyl-
ase gene (ermB) that confers macrolide, lincosamide, and
streptogramin B resistance.
The use of PCR fragment length polymorphism analysis to
detect intergenic insertion sequences has been previously de-
scribed (13, 19). PCR analysis of the intergenic regions of
Tn1546 was done to detect heterogeneity among the 49 vanA
isolates. Two types of Tn1546 element were identified. Thirty-
nine VRE carried IS1251 in the vanSH intergenic region (Ta-
ble 2, isolates not in boldface), and no other polymorphisms
were detected. No insertion sequences were detected in the
second type of Tn1546 element, carried by 10 isolates. To date,
IS1251 has only been identified in VRE isolated from hospitals
in the United States (9, 12, 13, 21). A number of polymorphic
Tn1546 types have been identified among VRE in the United
States (5, 9, 12, 13, 21); it would be of interest to know how
many of the types are endemic to public hospitals in Texas.
All isolates were examined by pulsed-field gel electrophore-
sis (PFGE) as previously described (15). Twenty-one PFGE
types, arbitrarily designated A to U and represented by three
groups (groups I, II, and III), were detected among the 50
VRE isolates (Fig. 1). Group I included 39 isolates (78%), the
most predominant being PFGE type A (n  23). All type A
clones were indistinguishable by antimicrobial susceptibility
profile and molecular analysis. Type A clones were dissemi-
nated among four geographically separated swine farm loca-
tions (TX1 to TX4) (Table 2). The distance between farm sites
ranged up to 200 km. Twenty (87%) of the type A clones were
isolated in June and July of 2003; however, three were isolated
in April 2004.
All group I VRE were isolated from farm facilities with the
exception of VRE 749 and 751 (85.3% similarity coefficient),
both of which were isolated from a hospital facility (TX6)
(Table 2) in June 2004.
At TX1 and TX3, VRE were only isolated once. VRE per-
sisted through the duration of this study at TX2 and TX4. The
greatest degree of heterogeneity among VRE was observed
from those isolated at TX4. The presence of related VRE
PFGE group I and II isolates from 2002 to 2004 may suggest
the ability of VRE to persist in the study community or in
community wastewater over extended periods of time. The
presence of identical VRE clones (PFGE type A) at multiple
geographically separated farm sites demonstrates the occur-
rence of clonal VRE dissemination.
All human subjects were enrolled at the central core facility
(TX7) and were subsequently assigned living quarters. Individ-
uals who had been in the system for long periods of time were
selected for farm work; once assigned, there was very little
movement of farm workers among farm sites. There was vir-
tually no movement of non-farm workers among any sites.
VRE carrier status was not known at the time of entry; how-
ever, none of the current farm workers would have entered the
system during the time period of this study. As in any commu-
nity population, individuals may have need of hospital (inpa-
tient) or dispensary (outpatient) services from time to time.
Each site is equipped with a dispensary. Because the medical
histories and documentation of movement among workers
were not available, the mechanism for dissemination to geo-
graphically separated sites is unknown. However, additional
population studies and genetic analyses of the VRE in this
study combined with VRE from hospital reservoirs in Texas
could conceivably trace the origin of these isolates.
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